{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:23:41Z","timestamp":1783556621539,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ejca.2020.07.038","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T08:31:19Z","timestamp":1599726679000},"page":"147-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Malignant peritoneal cytology in endometrial cancer"],"prefix":"10.1016","volume":"140","author":[{"given":"Ciro","family":"Pinelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Bogani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jvan","family":"Casarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Raspagliesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ghezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2020.07.038_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejca.2020.03.031","article-title":"Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer","volume":"133","author":"Matsuo","year":"2020","journal-title":"Eur J Canc"},{"issue":"20","key":"10.1016\/j.ejca.2020.07.038_bib2","first-page":"30991","article-title":"Survival outcomes in endometrial cancer patients having lymphadenectomy, sentinel node mapping followed by lymphadectomy and sentinel node mapping alone: long-term results of a propensity-matched analysis","volume":"S0090\u20138258","author":"Bogani","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2020.07.038_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/annonc\/mdv484","article-title":"ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up","volume":"27","author":"Colombo","year":"2016","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2020.07.038_bib4","first-page":"6","article-title":"Management of endometrial cancer: issues and controversies","volume":"37","author":"Bogani","year":"2016","journal-title":"Eur J Gynaecol Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2020.07.038_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ygyno.2013.04.013","article-title":"Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer","volume":"130","author":"Milgrom","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2020.07.038_bib6","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/ijgc-00009577-200807000-00032","article-title":"Does hysteroscopy affect prognosis in apparent early-stage endometrial cancer?","volume":"18","author":"Ben-Arie","year":"2008","journal-title":"Int J Gynecol Canc"},{"issue":"3","key":"10.1016\/j.ejca.2020.07.038_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial","volume":"19","author":"de Boer","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2020.07.038_bib8","article-title":"Phase III trial: adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel\/carboplatin in high-intermediate and high-risk early stage endometrial cancer","volume":"18","author":"Randall","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2020.07.038_bib9","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer","volume":"51","author":"Bosse","year":"2015","journal-title":"Eur J Canc"},{"issue":"3","key":"10.1016\/j.ejca.2020.07.038_bib10","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ygyno.2019.02.027","article-title":"Low-volume disease in endometrial cancer: the role of micrometastasis and isolated tumor cells","volume":"153","author":"Bogani","year":"2019","journal-title":"Gynecol Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920304494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920304494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:30:54Z","timestamp":1760733054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804920304494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":10,"alternative-id":["S0959804920304494"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2020.07.038","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malignant peritoneal cytology in endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2020.07.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2020.03.031","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}